STERIS plc
$223.73
▲
1.95%
2026-04-22 10:12:13
www.steris.com
NYQ: STE
Explore STERIS plc stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$21.95 B
Current Price
$223.73
52W High / Low
$269.44 / $209.98
Stock P/E
31.17
Book Value
$72.93
Dividend Yield
1.11%
ROCE
10.53%
ROE
10.47%
Face Value
—
EPS
$7.18
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
17,787
Beta
1.07
Debt / Equity
28.65
Current Ratio
2.48
Quick Ratio
1.39
Forward P/E
20.09
Price / Sales
3.75
Enterprise Value
$23.47 B
EV / EBITDA
14.9
EV / Revenue
4.03
Rating
None
Target Price
$279.29
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 2. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 3. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 4. | Bluejay Diagnostics, Inc. | $1.97 | — | $1.94 M | — | -115.88% | -1.17% | $16.68 / $1.65 | $9.88 |
| 5. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
| 6. | Delcath Systems, Inc. | $10.88 | 139.76 | $377.34 M | — | 0.59% | 3% | $18.23 / $8.12 | $3.21 |
| 7. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.5 B | 1.46 B | 1.39 B | 1.48 B | 1.37 B | — |
| Operating Profit | 273.7 M | 268 M | 247.8 M | 279.62 M | 247.4 M | — |
| Net Profit | 192.8 M | 191.9 M | 177.4 M | 145.67 M | 173.5 M | — |
| EPS in Rs | 1.97 | 1.96 | 1.81 | 1.49 | 1.77 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 5.46 B | 5.14 B | 4.54 B | 4.22 B |
| Operating Profit | 960.84 M | 862.16 M | 791.59 M | 477.86 M |
| Net Profit | 614.64 M | 378.24 M | 107.03 M | 243.89 M |
| EPS in Rs | 6.27 | 3.86 | 1.09 | 2.49 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.15 B | 11.06 B | 10.82 B | 11.42 B |
| Total Liabilities | 3.53 B | 4.75 B | 4.73 B | 4.88 B |
| Equity | 6.6 B | 6.3 B | 6.08 B | 6.53 B |
| Current Assets | 2 B | 2.87 B | 2.01 B | 1.88 B |
| Current Liabilities | 1.02 B | 931.13 M | 861.84 M | 922.22 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.15 B | 973.27 M | 756.95 M | 684.81 M |
| Investing CF | 388.77 M | -887.36 M | -383.33 M | -666.56 M |
| Financing CF | -1.57 B | -85.19 M | -498.72 M | 115.83 M |
| Free CF | 778 M | 612.95 M | 394.98 M | 397.25 M |
| Capex | -370.09 M | -360.33 M | -361.97 M | -287.56 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 6.24% | 13.28% | 7.41% | — |
| Earnings Growth % | 62.5% | 253.4% | -56.12% | — |
| Profit Margin % | 11.26% | 7.36% | 2.36% | 5.77% |
| Operating Margin % | 17.6% | 16.78% | 17.45% | 11.31% |
| Gross Margin % | 44.01% | 43.17% | 43.66% | 44.59% |
| EBITDA Margin % | 24.89% | 27.49% | 29.63% | 23.9% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-17 | $0.63 |
| 2025-09-04 | $0.63 |
| 2025-06-10 | $0.57 |
| 2025-02-20 | $0.57 |
| 2024-11-19 | $0.57 |
Stock Splits
No stock split history available.